Leukemia Research
Volume 34, Issue 4 , Pages 438-446 , April 2010

Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: Results from the Hellenic Dendritic Cell Leukemia Study Group

  • Nikolaos J. Tsagarakis

      Affiliations

    • Flow Cytometry Laboratory, Department of Immunology, Athens Regional General Hospital “G. Gennimatas”, Mesogion Avenue 154, Athens 11527, Greece
    • Corresponding Author InformationCorresponding author at: Flow Cytometry Laboratory, Department of Immunology, Athens Regional General Hospital “G. Gennimatas”, Athens 11527, Greece. Tel.: +30 210 7470467; fax: +30 210 7470467.
    • ,
  • Nektaria A. Kentrou

      Affiliations

    • Flow Cytometry Laboratory, Department of Immunology, Athens Regional General Hospital “G. Gennimatas”, Mesogion Avenue 154, Athens 11527, Greece
    • ,
  • Konstantinos A. Papadimitriou

      Affiliations

    • Flow Cytometry Laboratory, Department of Immunology, Athens Regional General Hospital “G. Gennimatas”, Mesogion Avenue 154, Athens 11527, Greece
    • ,
  • Maria Pagoni

      Affiliations

    • Department of Hematology and Lymphoma, “Evangelismos” General Hospital, Athens, Greece
    • ,
  • Garyfallia Kokkini

      Affiliations

    • Clinical Hematology Unit, “Sismanoglio” General Hospital, Athens, Greece
    • ,
  • Helen Papadaki

      Affiliations

    • Department of Clinical Hematology, University of Crete Medical School, University General Hospital of Heraklion, Heraklion, Greece
    • ,
  • Vassiliki Pappa

      Affiliations

    • Haematology Department, University General Hospital “Attikon”, Haidari, Athens, Greece
    • ,
  • Theodoros Marinakis

      Affiliations

    • Department of Clinical Hematology, Athens Regional General Hospital “G. Gennimatas”, Athens, Greece
    • ,
  • Nikolaos I. Anagnostopoulos

      Affiliations

    • Department of Clinical Hematology, Athens Regional General Hospital “G. Gennimatas”, Athens, Greece
    • ,
  • Chrissanthi Vadikolia

      Affiliations

    • Department of Clinical Hematology-Bone Marrow Transplantation Unit, “George Papanikolaou” General Hospital, Thessaloniki, Greece
    • ,
  • Achilleas Anagnostopoulos

      Affiliations

    • Department of Clinical Hematology-Bone Marrow Transplantation Unit, “George Papanikolaou” General Hospital, Thessaloniki, Greece
    • ,
  • Maria K. Angelopoulou

      Affiliations

    • Department of Clinical Hematology, National and Kapodistrian University of Athens Medical School, “Laikon” General Hospital, Athens, Greece
    • ,
  • Evangelos Terpos

      Affiliations

    • Department of Clinical Hematology, 251 General Hospital of Hellenic Airforce, Athens, Greece
    • ,
  • Christos Poziopoulos

      Affiliations

    • 1st Department of Internal Medicine, 401 General Military Hospital of Athens, Athens, Greece
    • ,
  • Konstantinos Anargyrou

      Affiliations

    • Department of Clinical Hematology, 251 General Hospital of Hellenic Airforce, Athens, Greece
    • ,
  • Dimitra Rontogianni

      Affiliations

    • Department of Pathology, “Evangelismos” General Hospital, Athens, Greece
    • ,
  • Theodora Papadaki

      Affiliations

    • Hemopathology Laboratory, “Evangelismos” General Hospital, Athens, Greece
    • ,
  • Aikaterini Psarra

      Affiliations

    • Department of Immunology, “Evangelismos” General Hospital, Athens, Greece
    • ,
  • Flora N. Kontopidou

      Affiliations

    • Immunology Laboratory, “Laikon” General Hospital, Athens, Greece
    • ,
  • Dimitra Skoumi

      Affiliations

    • Flow Cytometry Laboratory, Department of Immunology, Athens Regional General Hospital “G. Gennimatas”, Mesogion Avenue 154, Athens 11527, Greece
    • ,
  • Stefanos I. Papadhimitriou

      Affiliations

    • Department of Laboratory Hematology, Athens Regional General Hospital “G. Gennimatas”, Athens, Greece
    • ,
  • Georgios Paterakis

      Affiliations

    • Flow Cytometry Laboratory, Department of Immunology, Athens Regional General Hospital “G. Gennimatas”, Mesogion Avenue 154, Athens 11527, Greece
    • ,
  • for the Hellenic Dendritic Cell Leukemia Study Group

Received 12 March 2009 ,Revised 5 September 2009 ,Accepted 5 September 2009.

References 

  1. O’Doherty U, Peng M, Gezelter S, Swiggard WJ, Betjes M, Bhardwaj N, et al. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology. 1994;82:487–493
  2. Thomas R, Lipsky PE. Human peripheral blood dendritic cell subsets. Isolation and characterization of precursor and mature antigen-presenting cells. J Immunol. 1994;153:4016–4028
  3. Olweus J, BitMansour A, Warnke R, Thomson PA, Carballido J, Picker LJ, et al. Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci USA. 1997;94:12551–12556
  4. Facchetti F, Vermi W, Mason D, Colonna M. The plasmacytoid monocyte/interferon producing cells. Virchows Arch. 2003;443(6):703–717
  5. DiGiuseppe JA, Louie DC, Williams JE, Miller DT, Griffin CA, Mann RB, et al. Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study. Am J Surg Pathol. 1997;21:1223–1230
  6. Kameoka J, Ichinohasama R, Tanaka M, Miura I, Tomiya Y, Takahashi S, et al. A cutaneous agranular CD2− CD4+ CD56+ “lymphoma”: report of two cases and review of the literature. Am J Clin Pathol. 1998;110:478–488
  7. Petrella T, Dalac S, Maynadié M, Mugneret F, Thomine E, Courville P, et al. CD4+CD56+ cutaneous neoplasms: a distinct hematological entity?. Am J Surg Pathol. 1999;23:137–146
  8. Chaperot L, Bendriss N, Manches O, Gressin R, Maynadie M, Trimoreau F, et al. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood. 2001;97:3210–3217
  9. Feuillard J, Jacob MC, Valensi F, Maynadié M, Gressin R, Chaperot L, et al. Clinical and biologic features of CD4(+)CD56(+) malignancies. Blood. 2002;99:1556–1563
  10. Khoury JD, Medeiros LJ, Manning JT, Sulak LE, Bueso-Ramos C, Jones D. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia. Cancer. 2002;94:2401–2408
  11. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed.. Lyon, France: International Agency for Research on Cancer; 2008;
  12. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(May):3768–3785
  13. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia. 1995;9:1783–1786
  14. Anargyrou K, Paterakis G, Boutsis D, Politou M, Papadhimitriou SI, Siakandaris M, et al. An unusual case of CD4+ CD7+ CD56+ acute leukemia with overlapping features of type 2 dendritic cell (DC2) and myeloid/NK cell precursor acute leukemia. Eur J Haematol. 2003;71:294–298
  15. Leroux D, Mugneret F, Callanan M, Radford-Weiss I, Dastugue N, Feuillard J, et al. CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique. Blood. 2002;99:4154–4159
  16. Herling M, Jones D. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells. Am J Clin Pathol. 2007;127:687–700
  17. Bueno C, Almeida J, Lucio P, Marco J, Garcia R, de Pablos JM, et al. Incidence and characteristics of CD4(+)/HLA DRhi dendritic cell malignancies. Haematologica. 2004;89:58–69
  18. Petrella T, Wechsler J, Courville P, de Muret A, Bosq J, Déchelotte P, et al. Hematodermic CD4/CD56 neoplasm. Ann Pathol. 2004;24:241–255
  19. Brody JP, Allen S, Schulman P, Sun T, Chan WC, Friedman HD, et al. Acute agranular CD4-positive natural killer cell leukaemia. Comprehensive clinicopathologic studies including virologic and in vitro culture with inducing agents. Cancer. 1995;75:2474–2483
  20. Gopcsa L, Banyai A, Jakab K, Kormos L, Tamaska J, Matolcsy A, et al. Extensive flow cytometric characterization of plasmacytoid dendritic cell leukemia cells. Eur J Haematol. 2005;75:346–351
  21. Petrella T, Bagot M, Willemze R, Beylot-Barry M, Vergier B, Delaunay M, et al. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. Am J Clin Pathol. 2005;123:662–675
  22. Rossi JG, Felice MS, Bernasconi AR, Ribas AE, Gallego MS, Somardzic AE, et al. Acute leukemia of dendritic cell lineage in childhood: incidence, biological characteristics and outcome. Leuk Lymphoma. 2006;47:715–725
  23. Reimer P, Rudiger T, Kraemer D, Kunzmann V, Weissinger F, Zettl A, et al. What is CD4+CD56+ malignancy and how should it be treated?. Bone Marrow Transplant. 2003;32:637–646
  24. Bekkenk MW, Jansen PM, Meijer CJ, Willemze R. CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature. Ann Oncol. 2004;15:1097–1108
  25. Lacombe F, Durrieu F, Briais A, Dumain P, Belloc F, Bascans E, et al. Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia. Leukemia. 1997;11:1878–1886
  26. Garnache-Ottou F, Feuillard J, Ferrand C, Biichle S, Trimoreau F, Seilles E, et al. Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia. Br J Haematol. 2009;145:624–636
  27. Petrella T, Comeau MR, Maynadié M, Couillault G, De Muret A, Maliszewski CR, et al. ‘Agranular CD4+ CD56+ hematodermic neoplasm’ (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol. 2002;26:852–862
  28. Knapp W, Stockinger H, Majdic O. Antibody-defined cell surface molecules of the immune system. Curr Opin Immunol. 1989–1990;2:884–891
  29. Jacob MC, Chaperot L, Mossuz P, Feuillard J, Valensi F, Leroux D, et al. CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells. Haematologica. 2003;88:941–955
  30. Béné MC, Feuillard J, Jacob MC. Groupe d’Etude Immunologique des Leucémies. Plasmacytoid dendritic cells: from the plasmacytoid T-cell to type 2 dendritic cells CD4+CD56+ malignancies. Semin Hematol. 2003;40:257–266
  31. Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, Miltenyi S, et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol. 2000;165:6037–6046
  32. Bayerl MG, Rakozy CK, Mohamed AN, Vo TD, Long M, Eilender D, et al. Blastic natural killer cell lymphoma/leukemia: a report of seven cases. Am J Clin Pathol. 2002;117:41–50
  33. Uchiyama N, Ito K, Kawai K, Sakamoto F, Takaki M, Ito M. CD2−, CD41+, CD56+ agranular natural killer cell lymphoma of the skin. Am J Dermatopathol. 1998;20:513–517
  34. Vermi W, Facchetti F, Rosati S, Vergoni F, Rossi E, Festa S, et al. Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes/interferon-producing cells associated with myeloid disorders. Am J Surg Pathol. 2004;28:585–595
  35. Mohty M, Jarrossay D, Lafage-Pochitaloff M, Zandotti C, Brière F, de Lamballeri XN, et al. Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment. Blood. 2001;98:3750–3756

PII: S0145-2126(09)00466-4

doi: 10.1016/j.leukres.2009.09.006

Leukemia Research
Volume 34, Issue 4 , Pages 438-446 , April 2010

Article Tools

* Image Usage & Resolution